Sort
53,477 grants matching “addiction”
PRECLINICAL DEVELOPMENT OF NOVEL SMOKING CESSATION PHARMACOTHERAPIES
$742,129Nurulain T Zaveri · Astraea Therapeutics, Llc · R44 · FY2015 · DA
Optimization and preclinical development of FAAH inhibitors for smoking cessation
$742,050Daniele Piomelli · University Of California-Irvine · DP1 · FY2012 · DA
Optimization and preclinical development of FAAH inhibitors for smoking cessation
$742,050Daniele Piomelli · University Of California-Irvine · DP1 · FY2011 · DA
Optimization and preclinical development of FAAH inhibitors for smoking cessation
$742,050Daniele Piomelli · University Of California-Irvine · DP1 · FY2014 · DA
RAE (Realize, Analyze, Engage)- A Digital Biomarker Based Detection and Intervention System for Stress and Craving During Recovery from Substance Abuse Disorders
$742,031Megan Rois Reinhardt · Continueyou, Llc · R44 · FY2022 · DA
Neuronal characterization of the ventral tegmental area
$741,970Marisela Morales · National Institute On Drug Abuse · ZIA · FY2010 · DA
Novel imaging agents of oxidative stress in the pathophysiology of the central nervous system
$741,829Kiel Neumann · University Of Virginia · R01 · FY2020 · EB
Clinic-level implementation of mHealth to improve HIV viral suppression for patients with substance use disorders
$741,799Ryan Patrick Westergaard · University Of Wisconsin-Madison · R01 · FY2022 · DA
Vaping Nicotine and Cannabis Across Adolescence and Young Adulthood
$741,796Adam Matthew Leventhal · University Of Southern California · R01 · FY2023 · CA
Three Strategies for Implementing Motivational Interviewing on Medical Inpatient
$741,746Steve Martino · Yale University · R01 · FY2014 · DA
Neural basis of behavior in freely moving macaques
$741,745Benjamin Y Hayden · University Of Minnesota · R01 · FY2021 · MH
Biased Kappa Opioid Agonists as Non-addictive Analgesics
$741,673Thomas J Martin · Wake Forest University Health Sciences · R01 · FY2021 · DA
Maternal Opioid Treatment: Human Experimental Research
$741,519Thomas Jefferson University · R01 · FY2005 · DA
Omics analysis of HIV during synthetic opioid exposure
$741,485Jason T Blackard · University Of Cincinnati · R61 · FY2021 · DA
RECRUITMENT CORE
$741,267Uma Rao · Meharry Medical College · G12 · FY2011 · RR
Trial of Integrated Smoking Cessation, Exercise, and Weight Management in SMI
$741,044Gail L Daumit · Johns Hopkins University · R01 · FY2014 · MH
Neural basis of behavior in freely moving macaques
$740,946Benjamin Y Hayden · Baylor College Of Medicine · R01 · FY2025 · MH
Neural basis of behavior in freely moving macaques
$740,946Benjamin Y Hayden · Baylor College Of Medicine · R01 · FY2024 · MH
Emergency Department-Initiated Medications for Alcohol Use Disorder
$740,914Kathryn Hawk · Yale University · R01 · FY2024 · AA
Incentives for Suppression of HIV-1 RNA in People Living with HIV
$740,886Kenneth Silverman · Johns Hopkins University · R01 · FY2017 · AI
Training and Education Core p270-287
$740,795Thomas Evan Eissenberg · Virginia Commonwealth University · P50 · FY2016 · DA
Phase 2 Selective DAT inhibitor for treatment of Obesity.
$740,782Frank Zemlan · P2d, Inc. · R44 · FY2012 · DK
The effects of exposure to violence on risk for substance abuse: neural mechanisms and community level moderators
$740,752Baldwin M Way · Ohio State University · R01 · FY2020 · DA
The effects of exposure to violence on risk for substance abuse: neural mechanisms and community level moderators
$740,398Baldwin M Way · Ohio State University · R01 · FY2019 · DA
Enhancing Relapse Prevention with rTMS: Dose-Response Parameters for Smoking Cessation
$740,303Christine Elizabeth Sheffer · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA